Audited Supplier
NY022
ISO, Halal
HPLC-MS, HPLC
Tablet, Capsule, Softgels, Tinctures, Liquids, Drops
Health Care Products, Medicine
Powder
Withania Somnifera Roots
Fine Powder
Yellow Brown
2.5% or 5.0%
5days
Nutrayours/ OEM
25kg/Drum
98%
China
1302199099
Product Description
- 100% NATURAL PRODUCT: No artificial colors or flavors
- Verified herb identity, confirmed highest quality of raw herb and the extract
- Best natural sources of herbs and raw materials: Every vendor is carefully picked to meet our high standards
- Third-party lab tested, pure Withania Somnifera Root Extract
Withania Somnifera Root Extract contains alkaloids, steroidal lactones, Ashwagandha Extract solanolactone and iron, alkaloids have sedative analgesic, blood pressure lowering function, drunk solanolactone has anti-inflammatory effect can inhibit the growth of cancer cells, can also be used for chronic inflammation such as lupus and rheumatic inflammation, reduce leucorrhea, improve sexual function and so on, but also contribute to the rehabilitation of chronic diseases. The application in Indian medicine is the same as the application of ginseng in Chinese herbal medicine, it can improve life vitality, and is mainly used in lndian herbal treatment to nourish the body,especially when overwork or mental fatigue, to restore energy, and has a significant effect on chronic fatigue syndrome.
Keywords:Withania Somnifera Root Extract; Ashwagandha Extract;Flavonoids;Withanolides
| Contaminants | |||
| Arsenic (As) | ≤ 2.0 mg/kg | Conforms | GB 5009.76 |
| Lead (Pb) | ≤ 3.0mg/kg | Conforms | GB 5009.75 |
| Mercury (Hg) | ≤ 0.1mg/kg | Conforms | GB 5009.17 |
| Cadmium(Cd) | ≤ 1.0 mg/kg | Conforms | GB 5009.15 |
| Solvent Residue | Meet Eur.Ph.7.0 <5.4> | Conforms | USP36 <61> |
| PesticidesResidue | Meet USP Requirements | Conforms | USP36 <561> |
| Microbiological | |||
| Total Plate Count | ≤ 1,0000 cfu/g | 30cfu/g | GB 4789.2 |
| Mold&Yeast | ≤ 1000 cfu/g | 15cfu/g | GB 4789.15 |
| E. Coli | Negative | Conforms | GB 4789.3 |
| Salmonella | Negative | Conforms | GB 4789.4 |
| Staphylococcus aureus | <10 cfu/g | <10 cfu/g | GB 4789.10 |
*The statements in this section have not been evaluated by the FDA or EFSA.References
1.Lopresti AL, Smith SJ, Malvi H, Kodgule R.Medicine (Baltimore). 2019 Sep;98(37):e17186. doi: 10.1097/MD.0000000000017186.PMID: 31517876
2.Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R.PLoS One. 2021 Sep 24;16(9):e0257843. doi: 10.1371/journal.pone.0257843. eCollection 2021.PMID: 34559859
3.Verma N, Gupta SK, Tiwari S, Mishra AK.Complement Ther Med. 2021 Mar;57:102642. doi: 10.1016/j.ctim.2020.102642. Epub 2020 Dec 15.PMID: 33338583
4.Akhgarjand C, Asoudeh F, Bagheri A, Kalantar Z, Vahabi Z, Shab-Bidar S, Rezvani H, Djafarian K.Phytother Res. 2022 Nov;36(11):4115-4124. doi: 10.1002/ptr.7598. Epub 2022 Aug 25.PMID: 36017529
5.J Altern Complement Med. 2018 Mar;24(3):243-248. doi: 10.1089/acm.2017.0183. Epub 2017 Aug 22.PMID: 28829155
